| Literature DB >> 35198334 |
Kruttika R Chitnis1, Ayesha C Shah1, Sharmila V Jalgaonkar1.
Abstract
OBJECTIVES: A complete and concise pre-clinical experimental research gives detailed information about the disease-specific model, prevents duplication, and saves animal life, money, as well as time. It will also allow readers to effectively interpret and evaluate the work and ensure that others can replicate the experiments described. The present study was conducted to assess the adequacy of animal details provided in published experimental animal studies.Entities:
Keywords: animal details; checklist; experimental; optimal reporting; reproducibility
Year: 2022 PMID: 35198334 PMCID: PMC8857553 DOI: 10.7759/cureus.21439
Source DB: PubMed Journal: Cureus ISSN: 2168-8184
Figure 1Flow diagram of retrieval and selection of articles from the Indian journal.
Figure 2Flow diagram of retrieval and selection of articles from the international journal.
Checklist of items for animal details (Domain A).
*Chi-square test, **Fisher's exact test; df: degrees of freedom, ARRIVE: Animal Research: Reporting of In Vivo Experiments
| Item No. | Checklist Items | Indian journal | International journal | Pearson Chi-square value | df | p-value | ||
| A. | Animal Details | Yes n (%) | No n (%) | Yes n (%) | No n (%) | |||
| 1. | Common name of animals/Animal species | 177 (100%) | 0 (0%) | 51 (100%) | 0 (0%) | - | -* | |
| 2. | Strain of the animals | 169 (95.48%) | 8 (4.5%) | 46 (90.19%) | 5 (9.81%) | 0.090** | ||
| 3. | Sub strain of the animals | 0 (0%) | 177 (100%) | 0 (0%) | 51 (100%) | - | -* | |
| 4. | Sex of the animals | 162 (91.53%) | 15 (8.47%) | 43 (84.31%) | 8 (15.67%) | 2.27 | 1 | 0.132* |
| 5. | Age or age range | 36 (20.34%) | 141 (79.66%) | 3 (5.88%) | 48 (94.12%) | 5.836 | 1 | 0.016* |
| 6. | Weight (mean) | 160 (90.4%) | 17 (9.6%) | 47 (92.15%) | 4 (7.85%) | 1.000** | ||
| 7. | Genetic modification status | 0 (0%) | 177 (100%) | 0 (0%) | 51 (100%) | - | -* | |
| 8. | Genotype | 0 (0%) | 177 (100%) | 0 (0%) | 51 (100%) | - | -* | |
| 9. | Housing and husbandry | 148 (83.62%) | 29 (16.38%) | 51 (100%) | 0 (0%) | 9.574 | 1 | 0.002* |
| 10. | Source of the animals | 91 (51.41%) | 86 (48.59%) | 30 (58.82%) | 21 (41.18%) | 0.873 | 1 | 0.350 |
| 11. | Health and immune status of animals | 0 (0%) | 180 (100%) | 0 (0%) | 51 (100%) | - | - | |
| 12. | Drug used or drug naïve | 1 (0.55%) | 176 (99.44%) | 0 (0%) | 51 (100%) | 1.000** | ||
| 13. | Previous procedure | 0 (0%) | 177 (100%) | 0 (0%) | 51 (100%) | - | - | |
| 14. | Sample size calculation | 0 (0%) | 180 (100%) | 0 (0%) | 51 (100%) | - | - | |
| 15. | Sample size (No. of animals utilized for the study) | 150 (84.75%) | 27 (15.25%) | 47 (92.15%) | 4 (7.85%) | 1.851 | 1 | 0.174* |
| 16. | No. of control/ experimental groups | 154 (87.00%) | 23 (13.00%) | 48 (94.11%) | 3 (5.89%) | 1.982 | 1 | 0.159* |
| 17. | Randomization as per recommendation in ARRIVE guidelines | 0 (0%) | 177 (100%) | 0 (0%) | 51 (100%) | - | - | |
Checklist of items for disease model (Domain B).
*Chi-square test, **Fisher's exact test; df: degrees of freedom
| Item No. | Checklist Items | Indian journal | International journal | Pearson Chi-square value | df | p-value | ||
| B. | Disease Model | Yes n (%) | No n (%) | Yes n (%) | No n (%) | |||
| 1. | Disease/pathology studied | 125 (70.62%) | 52 (29.38%) | 44 (86.27%) | 7 (13.73%) | 5.058 | 1 | 0.025* |
| 2. | Rationale for using animals | 177 (100%) | 0 (0%) | 51 (100%) | 0 (0%) | - | - | |
| 3. | Rationale for the species of animals selected to address the scientific objective | 0 (0%) | 177 (100%) | 0 (0%) | 51 (100%) | - | - | |
| 4. | Outcome measures selected to address the scientific objective | 177 (100%) | 0 (0%) | 51 (100%) | 0 (0%) | - | - | |
| 5. | Experimental model | 81 (45.76%) | 96 (54.24%) | 29 (56.86%) | 22 (43.14%) | 1.954 | 1 | 0.162* |
| 6. | Intervention tested-Therapeutic or prophylactic | 169 (95.48%) | 8 (4.52%) | 51 (100%) | 0 (0%) | 0.204** | ||
| 7. | Procedure | 177 (100%) | 0 (0%) | 51 (100%) | 0 (0%) | - | - | |
| 8. | Statement regarding measures taken to minimize bias | 0 (0%) | 177 (100%) | 0 (0%) | 51 (100%) | - | - | |
Checklist of items for guidelines (Domain C).
*Chi-square test, **Fisher's exact test; df: degrees of freedom, CPCSEA: Committee for the Purpose of Control and Supervision of Experiments on Animals, OECD: Organisation for Economic Co-operation and Development
| Item No. | Checklist Items | Indian journal | International journal | Pearson Chi-square value | df | p-value | ||
| C. | Guidelines | Yes n (%) | No n (%) | Yes n (%) | No n (%) | |||
| 1. | Statement of adherence to CPCSEA/other country-specific guidelines | 92 (51.97%) | 85 (48.02%) | 37 (72.55%) | 14 (27.45%) | 6.820 | 1 | 0.009* |
| 2. | Statement of adherence to OECD guidelines | 45 (25.42%) | 132 (74.58%) | 22 (43.14%) | 29 (56.86%) | 5.987 | 1 | 0.014* |